Detected ·
Trace Biosciences
——
Trace Biosciences announces a strategic investment from Axogen, Inc. (NASDAQ: AXGN) as part of its Series A financing round to advance clinical development of NerveTrace Dx, a near-infrared fluorescence imaging agent designed to make nerves visible in real time during surgery.
- Website
- trace-bio.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-30 04:03:01 UTC
- Signal ID
- 6f7e4541-bc83-4775-9d61-1b9a7ef2f617
As the API returns it
{
"id": "6f7e4541-bc83-4775-9d61-1b9a7ef2f617",
"created_at": "2026-07-30T04:03:01.726572Z",
"company_name": "Trace Biosciences",
"company_website_url": "trace-bio.com",
"company_linkedin_url": "https://www.linkedin.com/company/trace-biosciences",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Trace Biosciences announces a strategic investment from Axogen, Inc. (NASDAQ: AXGN) as part of its Series A financing round to advance clinical development of NerveTrace Dx, a near-infrared fluorescence imaging agent designed to make nerves visible in real time during surgery.*"
}